Comparison of demographic and treatment characteristics, BVAS, and early VDI scores in patients with WG who survived (Group A) or died (Group B). Values are mean ± SD (median).
| Group A | Group B | p | |
|---|---|---|---|
| Age of disease onset, yrs | 41.2 ± 12.3 (42.5) | 56 ± 9.8 (55) | 0.002 |
| Time to diagnosis, mo | 6.9 ± 9.2 (4) | 4.8 ± 4.5 (3) | NS |
| Followup time, mo | 53 ± 34.1 (50) | 12.5 ± 11.1 (9) | < 0.001 |
| Early BVAS | 19.9 ± 7.4 (21) | 21.8 ± 5.9 (21) | NS |
| Early VDI | 2.6 ± 1.4 (2) | 4.8 ±1.8 (4.5) | 0.002 |
| Corticosteroid | |||
| Total dose | 17 ± 15.3 (13) | 7.4 ± 4.6 (6) | 0.002 |
| Total duration | 46.4 ± 31.3 (31) | 4.7 ± 5.7 (2) | < 0.001 |
| Cyclophosphamide | |||
| Total dose | 43.7 ± 33.2 (42) | 4.3 ± 8 (2) | < 0.001 |
| Total duration | 25.6 ± 21.2 (22) | 3.5 ± 5.1 (2) | < 0.0001 |